|
JPS5328935B2
(enExample)
|
1972-01-20 |
1978-08-17 |
|
|
|
JPS56104333A
(en)
|
1980-01-23 |
1981-08-20 |
Fuji Photo Film Co Ltd |
Color photographic sensitive material
|
|
DE3445669A1
(de)
|
1984-12-14 |
1986-06-19 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
JPS6232459A
(ja)
|
1985-08-05 |
1987-02-12 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS6238463A
(ja)
|
1985-08-14 |
1987-02-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−感光材料の画像形成方法
|
|
JPH067250B2
(ja)
|
1985-10-18 |
1994-01-26 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料
|
|
JPS6292939A
(ja)
|
1985-10-19 |
1987-04-28 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
JPH0756566B2
(ja)
|
1985-11-06 |
1995-06-14 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62129853A
(ja)
|
1985-11-30 |
1987-06-12 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
|
JPS62153953A
(ja)
|
1985-12-27 |
1987-07-08 |
Fuji Photo Film Co Ltd |
カラ−写真感光材料
|
|
JPS62173466A
(ja)
|
1986-01-28 |
1987-07-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS62222251A
(ja)
|
1986-02-17 |
1987-09-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62257158A
(ja)
|
1986-04-30 |
1987-11-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
DE3788600T2
(de)
|
1986-07-22 |
1994-04-28 |
Fuji Photo Film Co Ltd |
Verfahren zur Behandlung eines farbphotographischen Silberhalogenidmaterials.
|
|
DE3803775A1
(de)
|
1988-02-09 |
1989-08-17 |
Boehringer Mannheim Gmbh |
Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
|
JPH02234158A
(ja)
|
1989-03-07 |
1990-09-17 |
Fuji Photo Film Co Ltd |
カラー感光材料
|
|
JPH02264946A
(ja)
|
1989-04-05 |
1990-10-29 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
JPH02267548A
(ja)
|
1989-04-10 |
1990-11-01 |
Fuji Photo Film Co Ltd |
画像形成法
|
|
DE3925584A1
(de)
|
1989-08-02 |
1991-02-07 |
Boehringer Mannheim Gmbh |
Neue n-(dimethyloxophosphinylmethyl-)-lactame, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
DE4027592A1
(de)
|
1990-08-31 |
1992-03-05 |
Beiersdorf Ag |
Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
|
|
JPH04315148A
(ja)
|
1991-04-15 |
1992-11-06 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
GB9205702D0
(en)
|
1992-03-16 |
1992-04-29 |
Fujisawa Pharmaceutical Co |
A new use of a quinazoline derivative
|
|
DE69310098T2
(de)
|
1992-10-15 |
1997-07-31 |
Fuji Photo Film Co., Ltd., Minami-Ashigara, Kanagawa |
Verarbeitungsverfahren für farbphotographisches Silberhalogenidmaterial
|
|
DE69528829T2
(de)
|
1994-05-27 |
2003-08-07 |
Merck & Co., Inc. |
Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
|
|
US5756502A
(en)
|
1994-08-08 |
1998-05-26 |
Warner-Lambert Company |
Quinazolinone derivatives as cholyecystokinin (CCK) ligands
|
|
TW381092B
(en)
*
|
1995-07-07 |
2000-02-01 |
Otsuka Pharma Co Ltd |
Novel benzimidazole derivatives for use in treating arteriosclerotic diseases
|
|
US5747235A
(en)
|
1996-01-26 |
1998-05-05 |
Eastman Kodak Company |
Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
|
|
AU712082B2
(en)
|
1996-02-28 |
1999-10-28 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5780480A
(en)
|
1996-02-28 |
1998-07-14 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
CA2276081A1
(en)
|
1996-12-30 |
1998-07-09 |
Lekhanh O. Tran |
Inhibitors of farnesyl-protein transferase
|
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
|
CA2313125A1
(en)
|
1997-12-12 |
1999-06-24 |
Laramie Mary Gaster |
Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
|
|
ES2153809T3
(es)
|
1997-12-22 |
2005-07-16 |
Bayer Pharmaceuticals Corporation |
Inhibicion de la cinasa raf por uso de difnil-ureas sustituidas simetrica y asimetricamente.
|
|
DE19839499A1
(de)
|
1998-08-29 |
2000-03-02 |
Merck Patent Gmbh |
2-Oxo-2H-chinolinderivate
|
|
EP1255741A2
(en)
|
2000-02-01 |
2002-11-13 |
Cor Therapeutics, Inc. |
2- 1H]-QUINOLONE AND 2- 1H]-QUINOXALONE INHIBITORS OF FACTOR Xa
|
|
JP2002341484A
(ja)
|
2001-03-12 |
2002-11-27 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
JP2002296731A
(ja)
|
2001-03-30 |
2002-10-09 |
Fuji Photo Film Co Ltd |
熱現像カラー画像記録材料
|
|
WO2002090347A1
(en)
|
2001-04-30 |
2002-11-14 |
Fujisawa Pharmaceutical Co., Ltd. |
Amide compounds
|
|
JP2004529943A
(ja)
|
2001-05-15 |
2004-09-30 |
イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー |
殺菌・殺カビ剤としてのピリジニル縮合二環式アミド
|
|
JP2003321472A
(ja)
|
2002-02-26 |
2003-11-11 |
Takeda Chem Ind Ltd |
Ｇｒｋ阻害剤
|
|
EP1388342A1
(en)
|
2002-08-07 |
2004-02-11 |
Aventis Pharma Deutschland GmbH |
Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
|
|
JP4613130B2
(ja)
|
2002-08-23 |
2011-01-12 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
ベンゾイミダゾールキノリノンおよびそれらの使用
|
|
US7825132B2
(en)
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
|
EP1545526A4
(en)
|
2002-09-17 |
2009-09-23 |
Merck & Co Inc |
REMOVAL OF ALDEHYDE POLLUTION BY REACTIVE POLYSTYRENE RESIN
|
|
EP1572212A2
(en)
|
2002-12-11 |
2005-09-14 |
7TM Pharma A/S |
Quinoline compounds for use in mch receptor related disorders
|
|
US20040142950A1
(en)
|
2003-01-17 |
2004-07-22 |
Bunker Amy Mae |
Amide and ester matrix metalloproteinase inhibitors
|
|
US7205318B2
(en)
|
2003-03-18 |
2007-04-17 |
Bristol-Myers Squibb Company |
Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
|
|
JP4847868B2
(ja)
|
2003-05-14 |
2011-12-28 |
ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド |
化合物、及び、アミロイドベータの調節におけるその使用
|
|
AU2004249664A1
(en)
|
2003-05-19 |
2004-12-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
MXPA06004194A
(es)
|
2003-11-07 |
2006-06-28 |
Chiron Corp |
Inhibicion de fgfr3 y tratamiento de mieloma multiple.
|
|
WO2005087742A1
(en)
|
2004-03-08 |
2005-09-22 |
Exelixis, Inc. |
Metabolic kinase modulators and methods of use as pesticides
|
|
WO2005094805A1
(ja)
|
2004-04-01 |
2005-10-13 |
Institute Of Medicinal Molecular Design. Inc. |
イミン誘導体及びアミド誘導体
|
|
US7312335B2
(en)
|
2004-06-03 |
2007-12-25 |
Brandeis University |
Asymmetric Michael and Aldol additions using bifunctional cinchona-alkaloid-based catalysts
|
|
GB0416730D0
(en)
|
2004-07-27 |
2004-09-01 |
Novartis Ag |
Organic compounds
|
|
EP1655295A1
(en)
*
|
2004-11-03 |
2006-05-10 |
Schering Aktiengesellschaft |
Anthranilamide pyridinureas as VEGF receptor kinase inhibitors
|
|
UY29198A1
(es)
|
2004-11-09 |
2006-05-31 |
Cancer Rec Tech Ltd |
Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones
|
|
US20060281763A1
(en)
|
2005-03-25 |
2006-12-14 |
Axon Jonathan R |
Carboxamide inhibitors of TGFbeta
|
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
|
GB0509224D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of intracellular enzymatic activity
|
|
WO2006130437A2
(en)
|
2005-05-27 |
2006-12-07 |
Brandeis University |
Asymmetric carbon-carbon-bond-forming reactions catalyzed by bifunctional cinchona alkaloids
|
|
CA2623541A1
(en)
|
2005-09-23 |
2007-03-29 |
Coley Pharmaceutical Group, Inc. |
Method for 1h-imidazo[4,5-c]pyridines and analogs thereof
|
|
JP2009526798A
(ja)
|
2006-02-16 |
2009-07-23 |
シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト |
二環式ビスアミド構造を含む殺虫剤
|
|
GB0605689D0
(en)
|
2006-03-21 |
2006-05-03 |
Novartis Ag |
Organic compounds
|
|
US7601716B2
(en)
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
|
ATE528002T1
(de)
|
2006-05-19 |
2011-10-15 |
Bayer Pharma AG |
Pyridoncarboxamidderivate zur behandlung hyperproliferativer und angiogenese-vermittelter leiden
|
|
WO2008029152A2
(en)
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
|
US9987277B2
(en)
|
2006-10-04 |
2018-06-05 |
Janssen Sciences Ireland Uc |
Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
WO2008103277A2
(en)
|
2007-02-16 |
2008-08-28 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
|
|
WO2008109180A2
(en)
*
|
2007-03-07 |
2008-09-12 |
Alantos Pharmaceuticals Holding, Inc. |
Metalloprotease inhibitors containing a heterocyclic moiety
|
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
|
JP2008280341A
(ja)
|
2007-04-12 |
2008-11-20 |
Sumitomo Chemical Co Ltd |
ヒドラジド化合物およびその防除用途
|
|
WO2009020677A2
(en)
|
2007-04-27 |
2009-02-12 |
University Of Rochester |
Compositions and methods for inhibiting g protein signaling
|
|
EP2008658A1
(en)
|
2007-06-28 |
2008-12-31 |
Bayer Schering Pharma Aktiengesellschaft |
Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
|
|
TWI534137B
(zh)
|
2007-09-17 |
2016-05-21 |
艾伯維巴哈馬有限公司 |
抗感染劑及其用途
|
|
JP2011524365A
(ja)
|
2008-06-11 |
2011-09-01 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
マラリアの処置に有用な化合物および組成物
|
|
US20100068204A1
(en)
|
2008-09-12 |
2010-03-18 |
Wyeth |
4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
|
|
WO2010045374A1
(en)
|
2008-10-15 |
2010-04-22 |
Gilead Palo Alto, Inc. |
3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors
|
|
CA2745864A1
(en)
|
2008-12-23 |
2010-07-01 |
F.Hoffmann-La Roche Ag |
Dihydropyridone amides as p2x7 modulators
|
|
BRPI1011477A2
(pt)
|
2009-03-02 |
2016-03-22 |
Sirtris Pharmaceuticals Inc |
quinolinas 8-substituidas e analogos relacionados como moduladores de sirtuina
|
|
US8278302B2
(en)
|
2009-04-08 |
2012-10-02 |
Boehringer Ingelheim International Gmbh |
Substituted piperidines as CCR3 antagonists
|
|
US8362249B2
(en)
|
2009-04-27 |
2013-01-29 |
Boehringer Ingelheim International Gmbh |
CXCR3 receptor antagonists
|
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
|
BR112012010706A2
(pt)
*
|
2009-11-05 |
2016-03-29 |
Glaxosmithkline Llc |
composto, composição farmacêutica, combinação do produto farmacêutico, uso de um composto, e, métodos para o tratamento de uma doença ou condição, e para inibir um bromodomínio
|
|
US20130109672A1
(en)
|
2010-04-29 |
2013-05-02 |
The United States Of America,As Represented By The Secretary, Department Of Health And Human Service |
Activators of human pyruvate kinase
|
|
AU2011254242B2
(en)
|
2010-05-17 |
2015-10-29 |
Incozen Therapeutics Pvt. Ltd. |
Novel 3,5-disubstitued-3H-imidazo[4,5-b]pyridine and 3,5- disubstitued -3H-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
|
|
WO2011156632A2
(en)
|
2010-06-09 |
2011-12-15 |
Georgetown University |
Compositions and methods of treatment for tumors in the nervous system
|
|
EP2604602A4
(en)
|
2010-08-11 |
2013-12-18 |
Taisho Pharmaceutical Co Ltd |
HETEROARYL PYRAZOLE DERIVATIVE
|
|
AR084070A1
(es)
*
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
EA026115B1
(ru)
|
2010-12-17 |
2017-03-31 |
Ф. Хоффманн-Ля Рош Аг |
Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение
|
|
TW201309639A
(zh)
|
2011-02-17 |
2013-03-01 |
Lg Life Sciences Ltd |
作為ｇｐｒ１１９促效劑之肟衍生物
|
|
WO2012125668A1
(en)
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
GB201106750D0
(en)
*
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
JP5742439B2
(ja)
|
2011-05-02 |
2015-07-01 |
信越化学工業株式会社 |
蛍光性化合物及び蛍光性樹脂組成物
|
|
US9278910B2
(en)
|
2011-05-31 |
2016-03-08 |
Receptos, Inc. |
GLP-1 receptor stabilizers and modulators
|
|
CN102887895B
(zh)
|
2011-07-22 |
2016-08-24 |
山东轩竹医药科技有限公司 |
吡啶并嘧啶类mTOR抑制剂
|
|
EP2736330A4
(en)
|
2011-07-29 |
2015-05-27 |
Tempero Pharmaceuticals Inc |
COMPOUNDS AND METHODS
|
|
WO2013027168A1
(en)
*
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
EP2766345B1
(en)
*
|
2011-10-14 |
2016-03-16 |
Bristol-Myers Squibb Company |
Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
|
|
CN104080452A
(zh)
|
2011-10-26 |
2014-10-01 |
美国政府健康及人类服务部 |
用小分子chk2抑制剂治疗hcv感染的方法
|
|
CA2870992C
(en)
|
2012-04-25 |
2020-07-14 |
Raqualia Pharma Inc. |
Amide derivatives as ttx-s blockers
|
|
JPWO2014034719A1
(ja)
|
2012-08-29 |
2016-08-08 |
興和株式会社 |
Ｔｌｒ阻害作用を有するキノリン誘導体
|
|
CN105229002A
(zh)
|
2012-12-20 |
2016-01-06 |
拜耳医药股份有限公司 |
抑制bet蛋白的二氢吡啶并吡嗪酮
|
|
JP2016509576A
(ja)
|
2012-12-20 |
2016-03-31 |
バイエル ファーマ アクチエンゲゼルシャフト |
Ｂｅｔタンパク質阻害性ジヒドロキノキザリノン類
|